GlassScriptPhysician profile
Gary Belt
NPI 1699707422
$1,935.96
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,386 · 2020: $215 · 2021: $150 · 2023: $184.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $150 · Education: $34.12.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $150.00 |
| Education | $34.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $536.21 | 2019-2023 | Tysabri |
| Alexion Pharmaceuticals, INC. | $211.19 | 2019-2023 | Ultomiris |
| Novartis Pharmaceuticals Corporation | $190.46 | 2019-2020 | |
| Merz North America, INC. | $140.05 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $116.80 | 2019-2020 | |
| Mdd US Operations, LLC | $92.25 | 2019-2020 | |
| Emd Serono, INC. | $79.89 | 2019 | |
| Eisai INC. | $71.03 | 2019-2020 | |
| Amneal Pharmaceuticals LLC | $69.29 | 2019-2020 | |
| Genzyme Corporation | $68.44 | 2019-2020 | |
| Ge Healthcare | $57.41 | 2019-2020 | |
| Ucb, INC. | $55.96 | 2019 | |
| Supernus Pharmaceuticals, INC. | $53.11 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $51.62 | 2019-2020 | |
| Boston Scientific Corporation | $36.50 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Adamas Pharmaceuticals, INC. | $14.94 | 2019 | |
| Akcea Therapeutics, INC. | $14.67 | 2019 | |
| Csl Behring | $14.58 | 2019 | |
| Lilly USA, LLC | $14.29 | 2020 | |
| Vertical Pharmaceuticals, LLC | $13.25 | 2019 | |
| Lundbeck LLC | $12.14 | 2020 | |
| Allergan, INC. | $11.03 | 2019 | |
| Acadia Pharmaceuticals INC | $10.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Belt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.